MOG and myeloid sarcoma: Until recently, it was speculated that MOG could be a potential autoantigen in multiple sclerosis (MS); however, this is not the case, as neuroinflammatory disease associated with MOG antibodies has a different clinical phenotype from MS with a range of manifestations [4].